Intellia Therapeutics Inc buy Oppenheimer Holdings Inc.
Start price
13.11.23
/
50%
€22.25
Target price
13.11.24
€65.39
Performance (%)
9.66%
Price
26.07.24
€24.40
Summary
This prediction is currently active. With a performance of 9.66%, the BUY prediction by Oppenheimer_Holdings for Intellia Therapeutics Inc is trending in the right direction. This prediction currently runs until 13.11.24. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | 5.857% | 5.857% |
iShares Core DAX® | 1.280% | 1.320% |
iShares Nasdaq 100 | -2.457% | -5.192% |
iShares Nikkei 225® | -2.006% | -1.389% |
iShares S&P 500 | -0.662% | -1.884% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat